Clinical Trial Update: Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.

View source ↗

Summary

An expanded access IND using autologous HB-adMSCS is described for bilateral knee pain due to knee osteoarthritis. The status indicates the program is no longer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• HB-adMSCS (Autologous) (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Knee Pain Chronic, Osteo Arthritis Knee | Status: NO_LONGER_AVAILABLE